Pace, a science and technology company, has appointed Andrew Fenny as President of Pace Life Sciences to drive the division’s strategic growth, focusing on enhanced support for pharmaceutical and biotech clients. Based in North Carolina’s Research Triangle Park, Fenny will oversee operations across all eight Pace Life Sciences sites and enhance service capabilities from early development to commercialization. With over 20 years of experience in the CDMO and pharmaceutical sectors, Fenny previously held leadership roles at SK Pharmteco and FUJIFILM Diosynth Biotechnologies. CEO Ken Beyer emphasized the need for partners who can guide clients through complex regulatory challenges, highlighting Fenny’s expertise as crucial for meeting these demands.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.contractpharma.com/breaking-news/andrew-fenny-joins-pace-life-sciences-as-president/
